Anthony Evnin - CMD Independent Director
Anthony Evnin is Portfolio Manager at CMD
Mr. Anthony B. Evnin, Ph.D., is an Independent Director of the company. He is Partner, Venrock, a VC firm, since 1975. Mr. Evnin currently serves on the Board of Directors of Juno Therapeutics, Inc., AVEO Pharmaceuticals, Inc., and Infinity Pharmaceuticals, Inc. as well as on the Board of one private company, Constellation Pharmaceuticals. He was formerly a Director of over 35 companies, both public and private, in the life sciences area. He is a Member of the Boards of Overseers and Managers of Memorial SloanKettering Cancer Center, a Trustee of The Jackson Laboratory, a Director of the New York Genome Center, a Member of the Board of Directors of the Albert and Mary Lasker Foundation, a Trustee Emeritus of Princeton University, and a Trustee Emeritus of The Rockefeller University.
| Age | 78 |
| Tenure | 8 years |
| Phone | 973 890-7270 |
| Web | www.cantelmedical.com |
Anthony Evnin Latest Insider Activity
Tracking and analyzing the buying and selling activities of Anthony Evnin against CMD etf is an integral part of due diligence when investing in CMD. Anthony Evnin insider activity provides valuable insight into whether CMD is net buyers or sellers over its current business cycle. Note, CMD insiders must abide by specific rules, including filing SEC forms every time they buy or sell CMD'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Anthony Evnin over two weeks ago Disposition of 12132 shares by Anthony Evnin of CMD at 80.59 subject to Rule 16b-3 | ||
Anthony Evnin over a month ago Disposition of 12132 shares by Anthony Evnin of CMD at 80.59 subject to Rule 16b-3 | ||
Anthony Evnin over two months ago Acquisition by Anthony Evnin of 1935 shares of CMD subject to Rule 16b-3 | ||
Anthony Evnin over two months ago Acquisition by Anthony Evnin of 1935 shares of CMD subject to Rule 16b-3 |
CMD Management Efficiency
The company has Return on Asset of 4.24 % which means that on every $100 spent on assets, it made $4.24 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 6.19 %, implying that it generated $6.19 on every 100 dollars invested. CMD's management efficiency ratios could be used to measure how well CMD manages its routine affairs as well as how well it operates its assets and liabilities.CMD has 1.01 B in debt with debt to equity (D/E) ratio of 1.28, which is OK given its current industry classification. CMD has a current ratio of 2.67, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist CMD until it has trouble settling it off, either with new capital or with free cash flow. So, CMD's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CMD sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CMD to invest in growth at high rates of return. When we think about CMD's use of debt, we should always consider it together with cash and equity.
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. Cantel Medical is listed under Medical Instruments Supplies in the United States and is traded on New York Stock Exchange exchange. CMD [CMD] is traded in USA and was established November 24, 2008. Management Performance
| Return On Equity | 6.19 | |||
| Return On Asset | 4.24 |
CMD Money Managers
| Peter Pronovost, Independent Director | ||
| Charles Diker, Chairman of the Board | ||
| Michael Drexel, Senior Vice President, Chief Technology Officer | ||
| Seth Yellin, Executive Vice President - Strategy and Corporate Development | ||
| George Fotiades, Chief Executive Officer, Director | ||
| Karen Prange, Independent Director | ||
| Mark Diker, Director | ||
| Ann Berman, Independent Director | ||
| Jeffrey Mann, Senior Vice President General Counsel, Secretary | ||
| Laura Forese, Independent Director | ||
| Peter Clifford, President, Chief Operating Officer | ||
| Alan Batkin, Presiding Independent Director | ||
| Jean Casner, Chief Human Resource Officer, Senior Vice President | ||
| Brian Capone, Senior Vice President - Chief Accounting Officer, Corporate Controller | ||
| Anthony Evnin, Independent Director | ||
| Shaun Blakeman, Chief Financial Officer, Senior Vice President | ||
| Ronnie Myers, Independent Director |
CMD Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is CMD a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 6.19 | |||
| Return On Asset | 4.24 | |||
| Profit Margin | 4.40 % | |||
| Operating Margin | 19.08 % | |||
| Current Valuation | 4.15 B | |||
| Shares Outstanding | 42.27 M | |||
| Shares Owned By Insiders | 21.04 % | |||
| Shares Owned By Institutions | 89.83 % | |||
| Number Of Shares Shorted | 2.49 M | |||
| Price To Earning | 73.80 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Tools for CMD Etf
When running CMD's price analysis, check to measure CMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CMD is operating at the current time. Most of CMD's value examination focuses on studying past and present price action to predict the probability of CMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CMD's price. Additionally, you may evaluate how the addition of CMD to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |